Vascular closure devices are required for the procedures following catherization to achieve hemostasis of the small hole created in the artery. Arterial closure devices (ACDs) are the most preferred vascular closure devices introduced in 1995 to reduce bed rest, time, pain, and discomfort associated with the mechanical compression technique. This helps in reduction of vascular complications and also decreases the time to hemostasis and ambulation. Mechanical compression technique was considered the gold standard before the introduction of vascular closure devices. Vascular closure devices are widely used in diagnostic and interventional procedures due to advantages such as reduced hemostasis and ambulation and increased patient comfort over the mechanical compression technique.
A sample of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=29861
An arterial closure device (ACD) along with a deployment tool comprises an arterial closure system. ACD is deployed within the contacting site vessel with the help of deployment tool. Arterial closure devices (ACDs) are of two types: active closure devices and passive closure devices. Active closure devices include suture devices, collagen plug devices, and clips. Passive closure devices are helpful for providing mechanical compression with enhanced hemostasis. These include hemostasis pads and compression devices such as FemoStop, Boomerang, Safeguard, Chito-Seal, and D-Stat.
Increasing geriatric population due to advancement in health care techniques, rising need of endovascular procedures, reduced complications with the use of ACDs, reimbursement of diagnostic procedures involved, and comfort to the patients are the factors driving the arterial closure devices (ACDs) market. However, less adoption in developing countries, increased cost of implantable arterial devices, and high incidence of leg ischemia are the factors restraining the market.
The arteriotomy closure devices (ACDs) market has been segmented based on type of device, application, and region. In terms of type of device, the market has been segmented into passive closure devices and active closure devices. Passive closure devices include devices that assist in the mechanism of compression such as clamps/tamping devices, assisted coagulation, and sealants. Active closure devices include devices involved in immediate closure including collagen plug, sutures, polyglycolic acid devices, and extravascular clips. Collagen plug devices can be further categorized into angioseal and vasoseal. In terms of application, ACDs can be segmented to be used for procedures carried out by femoral arterial access and for procedures carried out by transradial arterial access. Femoral arterial access is the most widely used technique; however, increased interest in transradial arterial access has been observed as it reduces bleeding complications.
Geographically, the global ACDs market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the leading market for arteriotomy closure devices due to advancement in technology, involvement of diagnostic technique as reimbursement and increase in the need of vascular procedures. However, the ACDs market in some developing countries in Asia Pacific and Africa are likely to witness sluggish growth due to lack of health care advancements and adoption of complicated expensive techniques.
Key market players in the arteriotomy closure devices market include Abbott Vascular, Cardiva Medical, Arstatis, Cardinal Health, St. Jude Medical, Morris Innovative Research, and Scion BioMedical.
To view TOC of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=29861
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
A sample of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=29861
An arterial closure device (ACD) along with a deployment tool comprises an arterial closure system. ACD is deployed within the contacting site vessel with the help of deployment tool. Arterial closure devices (ACDs) are of two types: active closure devices and passive closure devices. Active closure devices include suture devices, collagen plug devices, and clips. Passive closure devices are helpful for providing mechanical compression with enhanced hemostasis. These include hemostasis pads and compression devices such as FemoStop, Boomerang, Safeguard, Chito-Seal, and D-Stat.
Increasing geriatric population due to advancement in health care techniques, rising need of endovascular procedures, reduced complications with the use of ACDs, reimbursement of diagnostic procedures involved, and comfort to the patients are the factors driving the arterial closure devices (ACDs) market. However, less adoption in developing countries, increased cost of implantable arterial devices, and high incidence of leg ischemia are the factors restraining the market.
The arteriotomy closure devices (ACDs) market has been segmented based on type of device, application, and region. In terms of type of device, the market has been segmented into passive closure devices and active closure devices. Passive closure devices include devices that assist in the mechanism of compression such as clamps/tamping devices, assisted coagulation, and sealants. Active closure devices include devices involved in immediate closure including collagen plug, sutures, polyglycolic acid devices, and extravascular clips. Collagen plug devices can be further categorized into angioseal and vasoseal. In terms of application, ACDs can be segmented to be used for procedures carried out by femoral arterial access and for procedures carried out by transradial arterial access. Femoral arterial access is the most widely used technique; however, increased interest in transradial arterial access has been observed as it reduces bleeding complications.
Geographically, the global ACDs market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the leading market for arteriotomy closure devices due to advancement in technology, involvement of diagnostic technique as reimbursement and increase in the need of vascular procedures. However, the ACDs market in some developing countries in Asia Pacific and Africa are likely to witness sluggish growth due to lack of health care advancements and adoption of complicated expensive techniques.
Key market players in the arteriotomy closure devices market include Abbott Vascular, Cardiva Medical, Arstatis, Cardinal Health, St. Jude Medical, Morris Innovative Research, and Scion BioMedical.
To view TOC of this report is available upon request @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=29861
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
No comments:
Post a Comment